Table 3

Independent predictors of use of antidiabetic medications with high risk of hypoglycemia in community-dwelling older veterans with diabetes and comorbid dementia with tight glycemic control

OR95% CIP value
Male sex1.771.19–2.630.004
Race/ethnicity
 White non-Hispanic (reference)
 Black non-Hispanic1.271.05–1.530.015
 Hispanic0.920.75–1.130.42
 Other0.840.60–1.160.28
Age
 65–74 years (reference)
 75–84 years1.281.13–1.45<0.001
 ≥85 years1.601.37–1.88<0.001
Has medication copay0.930.83–1.040.20
Congestive heart failure1.511.28–1.78<0.001
Valvular disease0.880.72–1.080.22
Peripheral vascular disease1.21.05–1.410.010
Hypertension1.100.97–1.260.14
Chronic lung disease0.940.82–1.080.38
Hypothyroidism0.910.77–1.080.28
Renal failure4.603.67–5.78<0.001
Solid tumor without metastasis0.970.83–1.130.67
Obesity1.010.82–1.260.91
Weight loss0.880.65–1.200.43
Fluid and electrolyte disorder0.830.70–1.000.047
Deficiency anemia0.960.84–1.100.59
Psychoses0.940.81–1.100.47
Depression0.850.74–0.980.026
Inpatient stay in FY20081.261.06–1.490.008
VA documentation of dementia1.090.97–1.220.16
  • Tight glycemic control, HbA1c <7% (53 mmol/mol). OR, odds ratio.